Same-day Discharge after Subcutaneous Implantable Cardioverter-defibrillator Implantation is Safe and Cost-effective.

Authors

• Jill Swinning, OhioHealth
• Kelli Fox, OhioHealth
• Sreedhar Billakanty, OhioHealth
• Shannon Brown, OhioHealth
• Nagesh Chopra, OhioHealth
• Eugene Fu, OhioHealth
• Jennifer James, OhioHealth
• Gregory Kidwell, OhioHealth
• James Kleman, OhioHealth
• Victoria Murnane, OhioHealth
• Steven Nelson, OhioHealth
• Allan Nichols, OhioHealth
• S Kay Nichols, OhioHealth
• Andrea Robinson, OhioHealth
• Anish Amin, OhioHealth

Document Type

Article

Publication Title

The Journal of innovations in cardiac rhythm management

Abstract

The feasibility and safety of same-day discharge after transvenous implantable cardioverter-defibrillator implantation is well-established. However, subcutaneous ICDs (S-ICDs) are now increasingly being implanted, and the feasibility, safety, and potential cost savings associated with same-day discharge after S-ICD placement has not been widely investigated. In a small cohort of patients (n = 24) who underwent S-ICD implantation at our institution, 54% were successfully discharged on the same day as their implant procedure. Procedure-related complications were not apparent in this sampling and the reduction in health care costs was high, suggesting this protocol has immense benefit in today's health care environment. As such, same-day discharge of S-ICD patients is appropriate to consider and should receive further attention.

First Page

4123

Last Page

4125

DOI

10.19102/icrm.2020.110602

Publication Date

6-15-2020

Recommended Citation

Swinning J, Fox K, Billakanty S, Brown S, Chopra N, Fu E, James J, Kidwell G, Kleman J, Murnane V, Nelson S, Nichols A, Nichols SK, Robinson A, Amin A. Same-day Discharge after Subcutaneous Implantable Cardioverter-defibrillator Implantation is Safe and Cost-effective. J Innov Card Rhythm Manag. 2020 Jun 15;11(6):4123-4125. doi: 10.19102/icrm.2020.110602. PMID: 32596027; PMCID: PMC7313622.